SynthesisFrontiers in public health2026

Economic evaluations of next-generation sequencing for targeted therapy in non-small cell lung cancer: a systematic review.

Zexiang Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.